530665.BO Stock Analysis
53
Neutral
Based on Eyestock quantitative analysis, 530665.BO`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Zenith Healthcare Ltd. engages in the manufacture of pharmaceuticals formulation in the forms of tablets, capsules, oral liquids and injections. The company is headquartered in Ahmedabad, Gujarat. The firm offers its products across various therapeutic segments, including antibiotics and anti-infective, gastrointestinal tract, analgesic/anti-inflammatory, cardiovascular system, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system and skin. Its products across antibiotics and anti-infective categories include Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension and Azithromycin Oral Suspension. Its product across the gastrointestinal category includes Ranitidine Hydrochloride Tablets. Its product across the cardiovascular system includes Lisinopril Tablets. Its products across the analgesic category include Paracetamol and Aceclofenac Tablets. The company offers contract manufacturing of all dosage forms.